Cowen Prime Advisors’s Intermolecular, Inc. IMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,000
| Closed | -$4K | – | 171 |
|
|
2019
Q2 | $4K | Hold |
3,000
| – | – | ﹤0.01% | 157 |
|
|
2019
Q1 | $3K | Hold |
3,000
| – | – | ﹤0.01% | 157 |
|
|
2018
Q4 | $3K | Hold |
3,000
| – | – | ﹤0.01% | 170 |
|
|
2018
Q3 | $4K | Hold |
3,000
| – | – | ﹤0.01% | 185 |
|
|
2018
Q2 | $5K | Hold |
3,000
| – | – | ﹤0.01% | 192 |
|
|
2018
Q1 | $4K | Hold |
3,000
| – | – | ﹤0.01% | 185 |
|
|
2017
Q4 | $4K | Hold |
3,000
| – | – | ﹤0.01% | 180 |
|
|
2017
Q3 | $3K | Hold |
3,000
| – | – | ﹤0.01% | 171 |
|
|
2017
Q2 | $3K | Hold |
3,000
| – | – | ﹤0.01% | 177 |
|
|
2017
Q1 | $3K | Sell |
3,000
-25,000
| -89% | -$26.1K | ﹤0.01% | 178 |
|
|
2016
Q4 | $27K | Sell |
28,000
-1,300,100
| -98% | -$1.28M | 0.01% | 151 |
|
|
2016
Q3 | $1.32M | Sell |
1,328,100
-1,556,109
| -54% | -$1.92M | 0.6% | 42 |
|
|
2016
Q2 | $4.27M | Sell |
2,884,209
-143,591
| -5% | -$290K | 2.07% | 12 |
|
|
2016
Q1 | $7.66M | Buy |
3,027,800
+528,800
| +21% | +$1.19M | 3.55% | 7 |
|
|
2015
Q4 | $5.8M | Buy |
2,499,000
+968,800
| +63% | +$2.03M | 2.56% | 9 |
|
|
2015
Q3 | $2.89M | Buy |
1,530,200
+310,500
| +25% | +$650K | 1.35% | 22 |
|
|
2015
Q2 | $2.4M | Buy |
1,219,700
+738,700
| +154% | +$1.37M | 0.94% | 26 |
|
|
2015
Q1 | $789K | Buy |
481,000
+155,000
| +48% | +$264K | 0.33% | 46 |
|
|
2014
Q4 | $629K | Buy |
326,000
+306,000
| +1,530% | +$651K | 0.25% | 55 |
|
|
2014
Q3 | $46K | Buy |
+20,000
| New | +$45.8K | 0.02% | 193 |
|
Cowen Prime Advisors's IMI Position: Q3 2019 in Review
Cowen Prime Advisors sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 3,000 shares — an estimated $4K sold.
Cowen Prime Advisors first reported a position in IMI in Q3 2014 and held it in 20 quarters. The position peaked at $7.66M in Q1 2016. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.
- Cowen Prime Advisors reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
- Cowen Prime Advisors sold 3,000 Intermolecular, Inc. shares in Q3 2019, an estimated $4K.
- Cowen Prime Advisors first reported a position in Intermolecular, Inc. in Q3 2014 and held it in 20 quarters.
- Cowen Prime Advisors's Intermolecular, Inc. position peaked at $7.66M in Q1 2016.
- 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.
Based on Cowen Prime Advisors's 13F filing for Q3 2019, filed 6 Nov 2019.